Clinical trial
A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein…
NCT00327002 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00327002 |
|---|---|
| Title | A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism |
| Official title | A Mechanistic Study of the Effects of LY518674 on HDL C Metabolism |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X |
| Intervention type | Drug |
| Interventions | LY518674 |
| Enrollment | 40 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | May 17, 2006 |
| Last update posted | Dec 11, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: